Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Growing Demand and Expanding Eligibility of GLP-1s Growing demand for GLP-1 medications continues to be a top factor in rising health care costs in 2026
However, this association was not observed at the 50 mg dose, and the analysis was based on only two trials with limited sample sizes
According to research from the University of Southern California, demand for semaglutide, a popular GLP-1 drug, surged by 442% between January 2021 and December 2023, partly due to a reduction in the stigma associated with obesity treatment.
this was followed by approval of vildagliptin, alogliptin, saxagliptin and lingaliptin [37]
US$ 25.28
US$ 29.76
US$ 29.22
US$ 24.16
